• HOME
  • NEWS
    • BIOENGINEERING
    • SCIENCE NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • FORUM
    • INSTAGRAM
    • TWITTER
  • CONTACT US
Thursday, May 19, 2022
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
    • BIOENGINEERING
    • SCIENCE NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • FORUM
    • INSTAGRAM
    • TWITTER
  • CONTACT US
  • HOME
  • NEWS
    • BIOENGINEERING
    • SCIENCE NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • FORUM
    • INSTAGRAM
    • TWITTER
  • CONTACT US
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Oncoscience: Altos Labs and the quest for immortality – Dr. Blagosklonny’s perspective

Bioengineer by Bioengineer
May 11, 2022
in Health
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

BUFFALO, NY- May 11, 2022 – A new research perspective was published in Oncoscience journal by Mikhail Blagosklonny, M.D., Ph.D., entitled, “Altos Labs and the quest for immortality: but can we live longer right now?”
 

Altos Labs and the quest for immortality: but can we live longer right now?

Credit: Impact Journals

BUFFALO, NY- May 11, 2022 – A new research perspective was published in Oncoscience journal by Mikhail Blagosklonny, M.D., Ph.D., entitled, “Altos Labs and the quest for immortality: but can we live longer right now?”
 

“Here I discuss how combining rapamycin with other modalities may let us live long enough to benefit from future discoveries in cellular reprogramming and what needs to be done at Altos Labs to make this happen.”
 

Altos Labs—a new anti-aging biotechnology company funded by multiple billionaire investors, including Jeff Bezos and Yuri Milner—has reported a focus on reprogramming cells in order to reverse the trajectory of diseases, and thus, reverse aging.
 

In his research perspective, Dr. Blagosklonny writes that potential life-extension with rapamycin may allow us to win time while awaiting future discoveries that will reverse aging.
 

“Rapamycin treatment is rapidly becoming a mainstream anti-aging intervention.” 
 

However, Dr. Blagosklonny also writes that rapamycin alone is unlikely to extend lifespan sufficiently to benefit from Altos Labs’ future discoveries in our lifetime.
 

“If Altos Labs would allocate a small percentage of its funding to develop rapamycin based drug combinations, then additional decades of life extension may be available 3–5 years from now.”
 

“The number of potential combinations with rapamycin is enormous.” 
 

Read Dr. Blagosklonny’s research perspective: https://www.oncoscience.us/article/552/text/ 

Correspondence to: Mikhail V. Blagosklonny 

Email: [email protected], [email protected] 

Keywords: aging; longevity; lifespan; geroscience; rapalogs; gerostatics

Follow Dr. Blagosklonny on Twitter: https://twitter.com/Blagosklonny

For media inquiries, please contact [email protected].

Oncoscience Journal Office
6666 East Quaker Str., Suite 1D
Orchard Park, NY 14127
Phone: 1-800-922-0957, option 4

###



Journal

Oncoscience

DOI

10.18632/oncoscience.552

Method of Research

Commentary/editorial

Subject of Research

Not applicable

Article Title

Altos Labs and the quest for immortality: but can we live longer right now?

Article Publication Date

22-Apr-2022

Share12Tweet7Share2ShareShareShare1

Related Posts

Scripps Research awarded $67 million by NIH to lead new Pandemic Preparedness Center

Scripps Research awarded $67 million by NIH to lead new Pandemic Preparedness Center

May 18, 2022
SARS-CoV-2 virus particles

NIAID announces antiviral drug development awards

May 18, 2022

Childhood circumstances and personality traits are associated with loneliness in older age

May 18, 2022

How three mutations work together to spur new SARS-CoV-2 variants

May 18, 2022

POPULAR NEWS

  • Weybourne Atmospheric Observatory

    Breakthrough in estimating fossil fuel CO2 emissions

    46 shares
    Share 18 Tweet 12
  • Hidden benefit: Facemasks may reduce severity of COVID-19 and pressure on health systems, researchers find

    44 shares
    Share 18 Tweet 11
  • Discovery of the one-way superconductor, thought to be impossible

    43 shares
    Share 17 Tweet 11
  • Sweet discovery could drive down inflammation, cancers and viruses

    43 shares
    Share 17 Tweet 11

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Tags

Weather/StormsUrogenital SystemViolence/CriminalsVirusWeaponryVaccinesVirologyUniversity of WashingtonZoology/Veterinary ScienceVehiclesUrbanizationVaccine

Recent Posts

  • New thermal management technology for electronic devices reduces bulk while improving cooling
  • Oncotarget | Anti-cancer drug profiling with CancerOmicsNet
  • DAP array casts a wide net to fix mutations
  • WVU engineer awarded funding to improve biometric identification by collecting large-scale biometric datasets
  • Contact Us

© 2019 Bioengineer.org - Biotechnology news by Science Magazine - Scienmag.

No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

© 2019 Bioengineer.org - Biotechnology news by Science Magazine - Scienmag.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
Posting....